Dosage Forms

Reshaping Dosage Forms

Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Frontrunners in Bispecific Antibodies

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Particle Sciences Gains DEA Schedule I Registration

May 28, 2019

Expanded controlled substance capabilities enables Particle Sciences to develop and manufacture Schedule I–V drugs.

Catalent Closes Acquisition of Paragon Bioservices

May 20, 2019

Catalent expands gene therapy capabilities with $1.2-billion acquisition of Paragon Bioservices.

Starch-Based Excipient for Direct Compression

May 16, 2019

StarTab from Colorcon was designed to ensure functionality and stability for direct compression tableting.

Best Practices for Developing Dry Powder Inhaler Combination Drug-Device Products

May 15, 2019

Consider both the device characteristics and the powder properties when developing a DPI combination product.

Test Methods and Quality Control for Prefilled Syringes

May 15, 2019

Empty and prefilled syringes must pass a range of quality control tests.

Recipharm Launches Development and Manufacturing Service for Inhalation Products

May 09, 2019

Recipharm Inhalation Solutions is an integrated service for inhalation products.

Working for the Greater Good

May 02, 2019

Pharma delivers a positive message with renewed efforts to eradicate malaria.

Catalent Invests $14 Million at Softgel Facility in Germany

April 24, 2019

Expansion at the Eberbach, Germany facility includes two Vegicap encapsulation lines, printing, inspection, and packaging capabilities.

GSK Invests $100 Million in Vaccine Manufacturing

April 24, 2019

Expansion at GSK’s Hamilton, MT site is designed to boost vaccine production capacity.

QC Lab Extends Capabilities at Cambrex’s Milan Facility

April 23, 2019

Pharmaceutical Technology's In the Lab eNewsletter

Cambrex’s expanded quality control laboratory supports generic API development.